US

Ruihong Chen

This inventor holds 0 USPTO granted patents, plus 6 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruihong Chen. Retrieved from https://idiyas.com/inventor/ruihong-chen-2q1dfqvr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0


Loading Chart...

Title: Innovations and Contributions of Inventor Ruihong Chen

Introduction

Ruihong Chen is an innovative inventor based in the United States. He has made significant contributions to the field of medical treatments, particularly in addressing neurofibromatosis and related neurodegenerative diseases. His work focuses on the application of specific compounds to inhibit tumor growth and treat neurofibromas.

Latest Patents

Ruihong Chen has developed several notable patents, including methods for the treatment of neurofibromatosis using radicicol and its derivatives. This invention outlines techniques for treating NF2-deficient or NF1-deficient cells and tumors by applying radicicol or its derivatives. Additionally, he has proposed a local treatment method for neurofibromas, which involves applying a composition directly to the affected area, avoiding systemic administration.

Career Highlights

Throughout his career, Ruihong Chen has worked with various organizations, including Nexgenix Pharmaceuticals, Inc. His expertise in the field has allowed him to contribute to advancements in medical treatments and therapies.

Collaborations

Ruihong Chen has collaborated with professionals in his field, including Xiaodong Shen, to further enhance his research and development efforts.

Conclusion

Ruihong Chen's innovative work in the treatment of neurofibromatosis and neurodegenerative diseases showcases his commitment to advancing medical science. His contributions are significant in the ongoing efforts to improve patient outcomes in these challenging areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…